NasdaqCM - Delayed Quote USD
GT Biopharma, Inc. (GTBP)
2.8900
+0.2200
+(8.24%)
At close: May 23 at 4:00:00 PM EDT
2.8800
-0.01
(-0.35%)
After hours: May 23 at 7:28:50 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|
| EPS Est. | -- | -1.55 | -0.64 |
| EPS Actual | -1.53 | -1.66 | -0.33 |
| Difference | -- | -0.11 | 0.31 |
| Surprise % | -- | -7.10% | 48.44% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GTBP | -- | -- | -- | -- |
| S&P 500 | 12.56% | 2.53% | 7.37% | 14.09% |
Upgrades & Downgrades
| Initiated | Roth MKM: Buy | 12/2/2024 |
Related Tickers
NNVC NanoViricides, Inc.
1.7900
+20.95%
NRXP NRx Pharmaceuticals, Inc.
2.6200
-2.60%
VTGN Vistagen Therapeutics, Inc.
2.4100
-0.82%
ABP Abpro Holdings, Inc.
0.2120
-7.83%
KTTA Pasithea Therapeutics Corp.
0.9153
-2.73%
BCLI Brainstorm Cell Therapeutics Inc.
1.0800
-2.70%
BDRX Biodexa Pharmaceuticals Plc
1.1500
-17.27%
NCNA NuCana plc
0.0380
-3.55%
PLRZ Polyrizon Ltd.
0.0034
-19.05%
ARMP Armata Pharmaceuticals, Inc.
1.8900
+1.07%